您好,欢迎来到皮书数据库!
热点推荐: 双循环
更多>> 课题组动态
更多>> 皮书作者
谢伏瞻
    中国社会科学院学部委员,学部主席团主席,研究员,博士生导师。历任中国社会科学院院长、党组书记,国务院发展中心副主... 详情>>
蔡 昉
    中国社会科学院国家高端智库首席专家,学部委员,学部主席团秘书长,研究员,博士生导师。先后毕业于中国人民大学、中国... 详情>>
李培林
    男,汉族,出生于1955年5月,山东济南人,博士,研究员,全国人民代表大会社会建设委员会副主任委员,中国社会科学... 详情>>

    阿尔茨海默病临床前期国人知晓率和主观就诊率调查研究

    摘要

    阿尔茨海默病(Alzheimer’sDisease,AD)目前尚无有效的治疗手段,AD临床前期主观认知下降(SubjectiveCognitiveDecline,SCD)是AD早期防治的重要靶点。因此,了解民众对AD及SCD的知晓情况以及主观就诊情况对于下一步的宣教工作和诊治策略制定至关重要。本研究通过线上问卷调查方式,在全国范围内发放AD和SCD知晓情况和就诊情况调查问卷。调查发现,在总调查人群中,AD的知晓率为97。08%,SCD的知晓率为82。63%,因认知下降主动去医院就诊的人员比例为78。17%。目前公众对AD和SCD的知晓率有了较高的提升,但了解程度仍有待提高。相关部门需要进一步加强宣教工作,提高民众对AD和SCD的重视程度,推进AD的早期防治。

    <<
    >>

    Abstract

    In Alzheimer’s disease(AD)is one of the most common cause of Alzheimer’s disease. However,there is still no effective treatment for AD. Individuals with subjective cognitive decline(SCD)is considered as a promising target population for AD prevention. Therefore,understanding the public’s awareness of AD and SCD is crucial for further education and treatment strategy development. We designed and distributed the questionnaire titled “the awareness rate and subjective visit rate for AD and SCD in China” based on the online method. The results showed that in the whole cohort,the awareness rate of AD was 97.08%,the awareness rate of SCD was 82.63%,and the proportion of deciding to look for medical help was 78.17%. At present,the public’s understanding of AD and SCD has been significantly improved,but the depth of their understanding still needs to be improved. More work is needed to increase the public’s attention to AD and SCD,and promote the early prevention and treatment of AD.

    <<
    >>
    作者简介
    王小琪:王小琪,首都医科大学宣武医院博士研究生,主要研究方向为阿尔茨海默病临床前期的早期诊治。
    韩璎:韩璎,首都医科大学宣武医院主任医师、教授,主要研究方向为阿尔茨海默病临床前期的早期诊治。
    <<
    >>
    相关报告